Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value

$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic fDA MAUDE Reports — Death

Quarterly figures from Medtronic's filings and investor materials

Quarterly Annual Monthly

Latest, Q1 FY27

454

Period ended Jul 31, 2026

Change on a year earlier

-7.7%

492 in Q1 FY26

History

51 quarters

Since Q3 FY14

Sources

U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	FDA MAUDE Reports — Death	Year on year	Source
Q1 FY27	Jul 31, 2026	454	-7.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY26	Apr 30, 2026	503	-3.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY26	Jan 31, 2026	474	+17.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY26	Oct 31, 2025	493	+23.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY26	Jul 31, 2025	492	+15.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY25	Apr 30, 2025	520	-13.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY25	Jan 31, 2025	403	-20.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY25	Oct 31, 2024	400	-16.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY25	Jul 31, 2024	427	-24.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY24	Apr 30, 2024	604	-10.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY24	Jan 31, 2024	504	+6.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY24	Oct 31, 2023	477	+32.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY24	Jul 31, 2023	566	0.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY23	Apr 30, 2023	676	+91.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY23	Jan 31, 2023	475	+19.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY23	Oct 31, 2022	359	+6.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY23	Jul 31, 2022	566	+73.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY22	Apr 30, 2022	354	-9.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY22	Jan 31, 2022	396	+16.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY22	Oct 31, 2021	338	-11.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY22	Jul 31, 2021	326	-10.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY21	Apr 30, 2021	391	+3.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY21	Jan 31, 2021	340	+13.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY21	Oct 31, 2020	382	+11.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY21	Jul 31, 2020	363	+1.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY20	Apr 30, 2020	377	-13.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY20	Jan 31, 2020	300	-14.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY20	Oct 31, 2019	342	-18.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY20	Jul 31, 2019	358	-35.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY19	Apr 30, 2019	437	+20.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY19	Jan 31, 2019	352	-3.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY19	Oct 31, 2018	420	+23.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY19	Jul 31, 2018	558	+111.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY18	Apr 30, 2018	364	+13.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY18	Jan 31, 2018	365	+44.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY18	Oct 31, 2017	339	+43.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY18	Jul 31, 2017	264	-1.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY17	Apr 30, 2017	322	-3.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY17	Jan 31, 2017	253	-26.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY17	Oct 31, 2016	236	-39.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY17	Jul 31, 2016	267	-40.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY16	Apr 30, 2016	335	-15.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY16	Jan 31, 2016	345	-20.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY16	Oct 31, 2015	392	-21.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY16	Jul 31, 2015	447	+5.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY15	Apr 30, 2015	394	-19.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY15	Jan 31, 2015	435	+306.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY15	Oct 31, 2014	496	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY15	Jul 31, 2014	425	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY14	Apr 30, 2014	488	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY14	Jan 31, 2014	107	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗

Cite this data

StockData. (2026). Medtronic FDA MAUDE Reports — Death, quarterly Q3 FY14–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-fda-maude-death

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.